SCHEMBL6485846

SCHEMBL6485846

O=C(O)CNBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3382017 0.80 ALDH1A1 (0.39)
SCHEMBL3379485 0.78 ALDH1A1 (0.38)
SCHEMBL8352247 0.69 LDHA (0.50)
SCHEMBL27023 0.69
SCHEMBL4816014 0.69 LMNA (0.50)
SCHEMBL3464176 0.67 LMNA (0.47)
Water SCHEMBL9703549 0.67 LMNA (0.47)
Ammonia Solution, Strong SCHEMBL7262621 0.67 LMNA (0.47)
SCHEMBL1305112 0.67
SCHEMBL9393647 0.67 LMNA (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240091121-A1 PHOSPHONATES AND N-HALAMINES COMPOSITIONS FOR TARTAR REMOVAL O.Y.M. INNOVATION LTD. (IL) 2024-03-21 US disclosed
EP-4274539-A2 PHOSPHONATES AND N-HALAMINES COMPOSITIONS FOR TARTAR REMOVAL O.Y.M. Innovation Ltd. (IL) 2023-11-15 EP disclosed
US-11814739-B2 Electrolytic production of organic chloramine solutions DE NORA HOLDINGS US, INC. (US) 2023-11-14 US disclosed
CN-116726146-A Inhalable compositions for the treatment of pulmonary diseases 呼吸治疗公司 2023-09-12 CN disclosed
CN-116688093-A Inhalable compositions for the treatment of pulmonary diseases 呼吸治疗公司 2023-09-05 CN disclosed
CN-116710046-A Phosphonic acid and N-halamine compositions for tartar removal O.Y.M.创新有限公司 2023-09-05 CN disclosed
US-20230159547-A1 COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME FUJIFILM CORPORATION (JP) 2023-05-25 US disclosed
CN-113164553-B Inhalable compositions for the treatment of pulmonary diseases 呼吸治疗公司 2023-04-21 CN disclosed
WO-2022149126-A2 PHOSPHONATES AND N-HALAMINES COMPOSITIONS FOR TARTAR REMOVAL O.Y.M. INNOVATION LTD. (IL) 2022-07-14 WO disclosed
EP-3469117-B1 ELECTROLYTIC PRODUCTION OF ORGANIC CHLORAMINE SOLUTIONS DE NORA HOLDINGS US INC (US) 2022-01-26 EP disclosed
EP-3925952-A1 PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER The Johns Hopkins University (US) 2021-12-22 EP disclosed
EP-2602261-A1 BORON COMPOUND WITH AMINO ACID SKELETON CONTAINING CYCLO RING Stella Pharma Corporation (JP) 2013-06-12 EP disclosed
US-6949655-B2 Acyclic piperidine derivatives VERTEX PHARMACEUTICALS INCORPORATED 2005-09-27 US disclosed
EP-1429767-A1 ACYLIC PIPERAZINE AND PIPERIDINE DERIVATIVES WHICH ARE USEFUL FOR TREATING NEURONAL DAMAGE Vertex Pharmaceuticals Incorporated (US) 2004-06-23 EP disclosed
US-20030191117-A1 Acyclic piperazine and piperidine derivatives VERTEX PHARMACEUTICALS INCORPORATED 2003-10-09 US disclosed
WO-2002102381-A9 ACYLIC PIPERAZINE AND PIPERIDINE DERIVATIVES WHICH ARE USEFUL FOR TREATING NEURONAL DAMAGE VERTEX PHARMA (US) 2003-03-06 WO disclosed
WO-2002102381-A1 ACYLIC PIPERAZINE AND PIPERIDINE DERIVATIVES WHICH ARE USEFUL FOR TREATING NEURONAL DAMAGE VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-12-27 WO disclosed